Promising drug may slow blindness in teens with rare eye disease
NCT ID NCT05244304
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This study tested a drug called tinlarebant in 104 teenagers (ages 12-20) with Stargardt disease, an inherited condition that causes progressive vision loss. The goal was to see if the drug could slow the growth of damage in the back of the eye. Participants received either the drug or a placebo, and researchers measured changes in eye scans and vision over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Belite Study Site
Palo Alto, California, 94303, United States
-
Belite Study Site
Minneapolis, Minnesota, 55435, United States
-
Belite Study Site
Salt Lake City, Utah, 84132, United States
-
Belite Study Site
Westmead, New South Wales, Australia
-
Belite Study Site
East Melbourne, Victoria, Australia
-
Belite Study Site
South Brisbane, Australia
-
Belite Study Site
Ghent, Belgium
-
Belite Study Site
Beijing, China
-
Belite Study Site
Shanghai, China
-
Belite Study Site
Paris, France
-
Belite Study Site
Bonn, Germany
-
Belite Study Site
Tübingen, Germany
-
Belite Study Site
Kowloon, Hong Kong
-
Belite Study Site
Nijmegen, Netherlands
-
Belite Study Site
Basel, Switzerland
-
Belite Study Site
Taipei, Taiwan
-
Belite Study Site
Taoyuan City, Taiwan
-
Belite Study Site
London, United Kingdom
-
Belite Study Site
Southampton, United Kingdom
Conditions
Explore the condition pages connected to this study.